ABSTRACT
INTRODUCTION
Diabetes mellitus(DM) is a chronic, hetero geneous and multifactorial disease; it is characterized by hyperglycemia due to impaired insulin secretion and aberrant glucagon secretion resulting from changes in the pancreatic islet cellsfunctions. 1 Most of diabetic patients are noninsulin dependent while small proportions have insulin dependent diabetes, 2 type 1 diabetes mellitus (T1DM) is a chronic disease results in a cellularmediated autoimmune destruction of β-cells of the pancreas, insulin deficiency and hyperglycemia are the main outcomes of it, 3 while in type 2 diabetes or adultonset Hyperglycemia is responsible for metabolic disturbances including oxidative stress which leads to injuries in the different cellular types of gastrointestinal tract and impair endogenous antioxidant defense system. 5 Oxidative stress due to autooxidation of glucose and decreased antioxidant defense is believed to play a role in the onset of DM and its complications. 6 The small intestine is unique in its variety of cell types including enterocytes (small intestinal epithelial cells), goblet cells (for mucus secre tion), enteroendocrine cells (for hormone secretion) and Paneth cells which are stem cells differentiate to form enterocytes. 7 Paneth cells located at the baseof the Lieberkühn glands 8 and they synthesize substances with antimicrobial properties such as α-defensins, lysozyme and phospholipase A 2 in response to different stimuli. 9 Paneth cells also control the composition of endog enous flora andplay a role in the crypt formation and developmentof phagocytosis, digestion and detoxification processes. 10, 11 Gammaamino butyric acid (GABA) is one of the main neurotransmitters in the central nervous system. It is produced from glutamate by decarboxylation via glutamic acid decarboxylase (GAD)activity and it creates biological signaling through activation of A and B types of GABA receptors. 12 GABA and GABAA receptors are found in nonneuronal cells of visceral organs. 13 It is known that GABA is a transmitter of enteric interneurons and it regulates the gastrointestinal tract functions.
14 GABA is also found in the epithelial cells of rat jejunum 15 and it has immune inhibitory effectsthat may protect β-cells of pancreas from autoimmune destruction.
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MATERIAL AND METHODS
Streptozotocin treatment
Streptozotocin (STZ) purchased from SigmaAldrich, St. Louis, Missouri, USA, within the type of one gram vials. Type 1 diabetes mellitus was induced by single intraperitoneal injection of rats with freshly prepared STZ at a dose of 60 mg/kg dissolved in 0.1M cold citrate buffer pH 4.5. 17, 18 Since STZ is capable of pro ducing fatal hypoglycemia as a result of massive pancre atic release of insulin, the rats were given 5% glucose for the next 24 hr to prevent hypoglycemia. 19 Blood glucose levels were determined using an Accucheck blood glucose meter (Roche Diagnostics, Basel, Switzerland). Three days following STZ injection the blood was withdrawn fromthe tail vein and glucose level was monitored. Rats with fasting blood glucose levels ≥ 250 mg/dl were considered as diabetic and included in the current study.
Treatment of rats with Gamma amino butyric acid
Gamma amino butyric acid (GABA) purchased from SigmaAldrich, St Louis, Missouri, USA in the form of 25 g vials was dissolved in distilled water and admin istered to rats daily by gastric gavages at doses of 200 mg/Kg body weight/day 20 for successive 3 weeks.
Animals
The present study was conducted on 40 adult male Swiss albino rats (Sprague dawley strain) (10 ± 2 weeks old; weighting 120 ± 10 g at the beginning of the experiment) purchased from the Egyptian company for Biological merchandise and Vaccines (Helwan, Cairo, EGYPT). They were kept for about 15 days, before the onset of the experiment under observation to be acclimatized to the laboratory conditions. Animals were housed collectively in plastic cages, maintained under standard conditions of light, ventilation, temperature and humidity and allowed free access of standard pellet diet and tap water. For biochemical analyses animals were sacrificed at 11:00 am ± 1 h. All animal procedures were carried out in accordance with the Ethics Committee of the National Research Centre followed to the "Guide for the Care and Use of Laboratory Animals" published by the US National Institutes of Health.
Animal groups
Experimental animals were randomly divided into 4 groups (n=10) treated in parallel and classified as following: 1. Control (C) group: Normal healthy rats administered 1ml distilled water daily during 3 weeks via gastric gavages. 2. GABA (G) group: Normal healthy rats adminis tered GABA (200 mg/Kg body weight/day) daily during 3 weeks via gastric gavages. 3. Diabetic (DM) group: STZ-treated rats adminis tered 1ml distilled water daily during 3 weeks via gastric gavages. 4. DM+GABA group: STZ-treated rats administered GABA (200 mg/Kg body weight/day) daily during 3 weeks via gastric gavages. 5. At the end of the third week rats were sacrificed after a fasting period of 12 hours next day to the last dose of GABA.
Biochemical analysis
Rats were anaesthetized with light ether, sacrificed and underwent laparotomy immediately. One cm segment of jejunum was dissected and washed with saline solution for the histological examinations. Other small segments of jejunum (10% w/v) were rapidly excised, homog enized in saline by using Teflon homogenizer (GlassCol, Terre Haute, Ind., USA) and after centrifugation at 10 kg for fifteen minutes using refrigerated centrifuge (manufactured by K3 Centurion Scientific, Ltd, London, UK) the supernatant was used for the estimation of markers of oxidative stress. Chemicals and reagents were purchased from SigmaAldrich, St Louis, MO, USA. Measurement of absorbance was accomplished by utilizing a T60 UV/VIS spectrophotometer, PG instruments, London, UK.
Assessment of oxidative stress in jejunal section
The extent of lipid peroxidation was assayed as described by Yoshioka et al., 21 advanced oxidation protein products (AOPPs) was determined according to the method of WitkoSarsatet al., 22 catalase activity was determined as described by Sinha 23 and glutathione peroxidase (GSHPx) activity was determined according to the method described by Necheleset al.
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Histopathologic examination
Tissue samples were fixed in 10% neutral buffered formalin and Carnoy's fixative and embedded in paraffin. The sections were cut at 5 µm and stained with hema toxylin and eosin (H&E) and Masson's trichrome stains for detection of the histological changes, 25 periodic acid Schiff 's (PAS) method 26 and Feulgen's reaction. 27 Sections were examined for mucosal injury, inflammation, conges tion and graded in a blinded manner by a pathologist. Sections stained with PAS were evaluated for goblet cell prevalence and Masson's trichrome stained sections were used to detect Paneth cells.
Morphometric and Cytometric analysis
For morphometric analysis, four whole circumference sections were examined. Also the number of villi and crypts per circumference, mucosal thickness, muscularis layer thickness and the outer intestinal boundary were estimated. Ten well orientated villi per segment were randomly selected and measured for villus height. Nuclear area, proliferation index and ploidy values of 100-150 cells within random fields were estimated in Feulgen's stained sections. All morphometric and cytometric parameters were done in the Pathology Department, National Research Centre employing the Leica Qwin 500 Image Analyzer (LEICA Imaging Systems Ltd, Cambridge, England,) that consists of Leica DMLB microscope provided with JVC color video camera attached to a computer system Leica Q 500IW. The results were recorded as the mean and standard deviation values.
Statistical analysis
The SPSS/PC computer program (version 20.0; SPSS Inc., Chicago, IL, USA) was used for statistical analysis of the results. Data were analyzed using oneway analysis of variance (ANOVA) followed by Post Hoc LSD test. The data which obtained were expressed as mean ± standard deviation (SD). Differences were thought of statistically significant once P value less than 0.05.
RESULTS
Biochemical measurements
Changes of oxidant and anti-oxidant biomarkers
The results obtained in the present study showed that the administration of gamma amino butyric acid (GABA) (200 mg/Kg/day) to normal rats (GABA group) for 3 weeks showed insignificant changes in catalase (CAT), glutathione peroxidase (GSHPx) activities, malondial dehyde (MDA) and advanced oxidation protein products (AOPPs) levels and they were within the normal values in the small intestine tissues Tables 1 and 2 . The administration of STZ to rats (DM group) showed a significant increase in AOPPs and MDA values and a significant decrease in CAT and GSH-Px values Tables 1  and 2 . Administration of GABA to STZtreated rats (DM+GABA group) improved the status of the above mentioned parameters Tables 2 and 3 which was evidenced by a significant increase in the antioxidants combined with a significant decrease in the oxidant biomarkers levels in small intestine tissues compared to those of the diabetic group. 
Diabetic group
Examined sections of this group showed villous and crypt hypertrophy, disturbed villous architecture was seen with some thick and other conical villi; other villi showed loss of epithelial coverings. Many of these villi appeared twisted or collapsed and others showed sepa ration of the epithelium from the underlying connective tissue core. Inflammatory cellular infiltration and edema of the villous core were seen with lymphoid hyperplasia. 
GABA treated diabetic group
Sections of diabetic and GABA treated rats showed slight villi hypertrophic changes with moderate lym phocytic infiltration. Goblet cells appeared normal and Paneth cells were of normal count and shape Figure 1 JL.
Morphometric and Cytometric analysis
Measured morphometric parameters of the examined sections showed a significant increase in the number of villi and crypts in the diabetic group. The mucosal height, the muscle layer thickness and the outer intestinal circumference increased significantly in the diabetic model compared to both the control and GABA groups demonstrating the effects of diabetes on the intestinal mucosa. The number of villi and crypts approximate somewhat near to the control value in the GABA treated diabetic group. Also, the mucosal height, the muscle layer thickness and the outer intestinal circum ference were significantly lower than those of the diabetic group Table 3 . Cytometric analysis of the diabetic group sections showed that the majority of epithelial cell nuclei have diploid DNA values with medium proliferation index and minor population of tetraploid cells comparable to the control and GABA treated groups. However, GABA treated diabetic group showed that the majority of epithelial cell nuclei have diploid DNA values with low proliferation index Table 4 and graph 1. The mean nuclear area was lower in GABA treated diabetic group as compared to the other groups. In the current study, a single intraperitoneal injection of 60 mg/kg body weight of STZ to male albino rats induced hyperglycemia, and insulin deficiency (similar to type 1 DM) that was proved by our previous study. 18 The decrease of insulin might result from hyperglycemia induced betacell toxicity 30 and degeneration of Langer hans islet beta cells. 19 STZ, an antibiotic produced by Streptomyces chromogenes, is the most commonly used agent in experimental diabetes. 31, 32 It was demonstrated that STZ induced damage to pancreatic cell membranes and evoked oxidative stress in islet cells. 33 In addition, STZ has been shown to induce DNA strand breaks and DNA alkylation in pancreatic islet cells. 34 Experimental studies demonstrated that STZ induces Type 1 DM or Type 2 DM, depending on the dose administered. 35 Administration of STZ to rats induced oxidative stress indicated by a significant increase in the oxidant bio markers values (AOPP and MDA) and a significant decrease in the antioxidants (catalase and GSHPx) activities, such observations come in coincidence with those reported by Eltahawy et al. 18 Oxidative stress plays an important role in cellular injury following hyper glycemia where high glucose level could stimulate free radical production process whereas weak body defense system becomes unable to counteract the enhanced reactive oxygen species (ROS) generation resulting in imbalance between ROS and their protection which finally lead to oxidative stress process. 36, 37 Several mech anisms have been reported to be responsible for oxidative stress in diabetes including excessive oxygen free radicals production from autooxidation of glucose, glycated proteins and glycation of antioxidative enzymes which inhibit their capacity to detoxify oxygen free radicals in addition to high glucose levels stimulation of cytochrome P 450 like activity by excessive nicotinamide adenine dinu cleotide phosphateoxidase (NADPH) resulting from glucose metabolism and ketosis, a hallmark of T1DM, which may increase oxygen free radicals production. 38 Results of the current experiment showed numerous histopathological changes in jejunum of STZinduced diabetic rats illustrated by villous and crypt hypertrophy, disturbed villous architecture of some villi and loss of epithelial covering of others. Inflammatory cellular infiltration and edema of the villous core with lymphoid hyperplasia were also depicted with increased number of goblet cells whereas Paneth cells disappeared or appeared degranulated. The majority of epithelial cell nuclei of the diabetic group had diploid DNA values with medium proliferation index. Such histopathologic findings come in collaboration with those observed by Abo Gazia and Hasan. 39 Mucosal hyperplasia may be contributed to hyperphagia, overproduction of gastrin, growth hormone and increased level of glucagonslike peptide2, upregulation of cell proliferation and inhibi tion of cell death via apoptosis. 40 In addition, surface epithelium sloughing and the necrotic cells appearance in some villi may be due to decreased blood supply resulted from the diabetic microangiopathy. 41 Moreover, villous inflammatory cellular infiltration of the diabetic rats may be attributed to bacterial overgrowth and parasitic infestation of the small intestine. 42 As well as many environmental toxins such as concomitant exposure to aluminum and ionizing radiation increased detrimental structural changes in Paneth cells. 43 In the past five decades, the function of GABA in the CNS has been well documented. However, the presence of a GABAergic system within the pancreas as a potential target for treatment diabetes mellitus appeared only recently. In α-cells, GABA induces membrane hyper polarization and inhibits glucagon secretion. In β-cells, GABA induces membrane depolarization and improves insulin secretion. GABA also has valuable effects on β-cell survival and regeneration, which results in enlarged β-cell mass. Moreover, GABA inhibits insulitis and systemic inflammatory cytokine production.
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The current experiment showed that GABA admini stration to normal rats for three weeks induced non significant effect on the studied parameters which corroborate previous report of Yoshikuni.
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According to the results of the current work, administra tion of GABA (200 mg/Kg/day) daily during a period of 3 weeks to STZ-treated rats lead to the significant improvement in all the studied parameters could be attributed to the role of GABA in improving insulin and glucose level as shown by our previous study 18 that attributing to GABA treatment increased β-cell prolif eration, while decreasing apoptosis, leading to enhanced β-cell mass. In addition, the activation of GABAA receptors in islet β-cells increases insulin release.
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Nevertheless, according to the results of the current work, the significant improvement in all the studied parameters could be attributed to the role of GABA in attenuating oxidative stress through increasing endog enous superoxide dismutase (SOD) and CAT activities, decreasing lipid peroxidation 49 due to its free radicals scavenging activities, 50 its effectiveness in inhibiting the formation of reactive carbonyl intermediates and to react with MDA, increased in diabetic subjects as a side effect of increased protein glycation, to form different conjugated complexes 51 thus protect the tissue against active carbonyl damage. Treatment of the diabetic rats with GABA reduced the severity of changes in the intestinal epithelial cells where the villi appeared slightly hypertrophic with moderate lymphocytic infiltration in the connective tissue core. Both goblet and Paneth cells were of normal count and shape. The majority of epithelial cells nuclei had diploid DNA values with low proliferation index, the mean nuclear area was lower in GABA treated diabetic group as compared to the other groups. In addition, treatment with GABA showed a significant increase in the antioxidants content associated with a significant decrease in the oxidant biomarkers values in the small intestine tissues indicating that GABA ameliorated the intestinal changes in STZinduced diabetic rats. GABA exert pancreatic β-cell regenerative effects as it protects β-cells against apoptosis and supported anti-inflamma tory and immunoregulatory activities. 44 Moreover, it exerted anti diabetic effects by acting on both the islet of β-cells and immune system, therapy preserving β-cell and preventing the development of T1DM. Moreover, it could suppress insulitis and inflammatory cytokines production 16 Furthermore, GABA has been shown to diminish inflammation by inhibition of activated T lymphocytes.
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CONCLUSION
Oxidative stress plays an important role in progression and development of the different types of diabetes in addition to associated complications and its complications. The current results showed that gamma aminobutyric acid (GABA) ameliorated most of the degenerative changes in STZinduced diabetes in rat's small intestine which may be attributed to its free radicals scavenging activities, its antioxidant properties and its role in regulating insulin level.
